During the COVID-19 pandemic, the behavior of self-medication has increased. The
dissemination of misleading information regarding the efficacy of certain drugs or …

Introduction The coronavirus disease 2019 (COVID-19) pandemic has put a strain on global
healthcare systems. Despite admirable efforts to develop rapidly new pharmacotherapies …

A major challenge in managing acute viral infections is ameliorating disease when treatment
is delayed. Previously, we reported the success of a 2-pronged mAb and antiviral remdesivir …

Objectives To understand differences in antimicrobial use between COVID-19 and non-
COVID-19 patients. To compare two metrics commonly used for antimicrobial use: Defined …

Background: Despite no evidence showing benefits of hydroxychloroquine and chloroquine
with or without azithromycin for COVID-19 treatment, these medications have been largely …

Despite the lightning-fast advances in the management of SARS-CoV after 2 years of
pandemic, COVID-19 continues to pose a challenge for fragile patients, who could benefit …

The COVID-19 pandemic has resulted in a complex clinical challenge, caused by a novel
coronavirus, partially similar to previously known coronaviruses but with a different pattern of …

Fundamento Apesar da ausência de evidência mostrando benefícios da hidroxicloroquina e
da cloroquina combinadas ou não à azitromicina no tratamento da covid-19, esses …

In Belgium, multiple guidances are in use by clinicians concerning the management of
patients with COVID-19 but specific recommendations for the treatment of non-severe …

Healthcare during the COVID-19 pandemic may have led to the inappropriate use of
antimicrobial agents and contributed to elevated multidrug resistance. The aim of this study …